Founded: 2020
Invested: 2020
Investment Director:
Arpesh Mehta
Description: Ripple Therapeutics was founded based on the discovery that drugs can be engineered into controlled-release pharmaceuticals without the use of polymers or excipients. By delivering the right amount of drug for the right amount of time, it can improve patient safety and clinical outcomes.
Focus area: Biomedical
Investors 1
| Date | Name | Website |
| - | DSM Ventur... | venturing.... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 20.03.2023 | Hovione and Ripple Enter Strategic Partnership to Expand Epi... | LISBON, Portugal, March 20, 2023 /PRNewswire/ -- Hovione, the specialist integrated CDMO, leader in ... | en.prnasia... |